Organon & Co.【OGN】Balance sheet

Market cap

$2.1B

P/E ratio

	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	737	706	693	675
Total cash & short-term investments	737	706	693	675
Accounts receivable, net	1,382	1,475	1,744	1,358
Inventories	915	1,003	1,315	1,321
Total current assets	3,760	3,931	4,508	4,348
Property, plant and equipment, net	973	1,018	1,183	1,168
Total non-current assets	6,921	7,024	7,550	8,753
Total assets	10,681	10,955	12,058	13,101
Accounts payable	1,382	1,132	1,314	1,153
Long-term debt, current	9	8	9	20
Total current liabilities	2,597	2,512	2,918	2,718
Long-term debt, non-current	9,125	8,905	8,751	8,860
Total non-current liabilities	-	-	9,210	9,911
Total liabilities	-	-	12,128	12,629
Common stock and paid-in capital	3	3	3	3
Retained earnings	-998	-331	443	1,010
Stockholders' equity	-1,508	-892	-70	472
Total debt	9,134	8,913	8,760	8,880
Net debt	8,397	8,207	8,067	8,205
D/E ratio (%)	-605.7	-999.2	-12,514.3	1,881.4
Working capital